Adjuvant chemotherapy after reduced craniospinal irradiation dose in children with average-risk medulloblastoma: a 5-year follow-up study.

Hanan Ahmed Wahba, Mohamed Abu-Hegazy, YasserF. M. Wasel, E Ismail, Ahmed Zidan

PubMed · 2013 · 16 citations · 20 references

Abstract

The preliminary results of adjuvant chemotherapy after reduced-dose CSI in average-risk medulloblastoma patients are encouraging and effective, and can be applied safely with acceptable toxicity.

References

20